 Connection
Michel Chonchol to Naphthalenes
This is a "connection" page, showing publications Michel Chonchol has written about Naphthalenes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.154 |
|
|
|
-
Jovanovich A, Chonchol M. Chronic kidney disease: Reductions in FGF-23 levels associated with improved outcomes. Nat Rev Nephrol. 2015 Oct; 11(10):572-3.
Score: 0.502
-
Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2009 Feb; 53(2):197-207.
Score: 0.318
-
Spiegel DM, Casey L, Bell S, Parker M, Chonchol M. Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice. Hemodial Int. 2006 Oct; 10 Suppl 2:S24-7.
Score: 0.272
-
Charytan C, Coburn JW, Chonchol M, Herman J, Lien YH, Liu W, Klassen PS, McCary LC, Pichette V. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis. 2005 Jul; 46(1):58-67.
Score: 0.062
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|